|
|||||
|
|
||||||
© 2003 American Society for Clinical Oncology
Challenging Problems in Advanced MalignancyCASE 1. CHYLOPERICARDIUM DURING THE TREATMENT OF NON-HODGKINS LYMPHOMAEwha Womans University, College of Medicine, Seoul, Korea
A 14-year-old boy presented with blood-tinged sputum and night sweats persisting for 3 months. He didnt have any weight loss or fever. Physical examination showed facial edema, supraclavicular lymphadenopathy, and absence of hepatosplenomegaly. The complete blood analysis showed a hemoglobin level of 12.8 g/dL, a leukocyte count of 7,700/µL with normal differential count, and a platelet count of 297,000/µL. Other biochemical tests were within normal range, except for lactate dehydrogenase, which was 2,300 U/mL. A chest x-ray film showed a large mediastinal mass. A computed tomography (CT) scan of the thorax confirmed a multilobulated, heterogenous mass extending from the manubrium to the diaphragm, and measuring 8 x 8 x 14 cm (Fig 1A
The patients symptoms improved by pericardial drainage and a low-lipid diet. Nine days after pericardial drainage, the amount of chylous drainage was decreased to 2 mL per day, and the tube was removed. No reaccumulation of pericardial fluid was observed. He continued chemotherapy treatment. The incidence of cardiac involvement by neoplasm in autopsy series is approximately 10%.1 The mechanical obstruction of lymphatic drainage is caused by postoperative or postirradiation fibrosis and superior vena cava syndrome. Chylopericardium is related to thoracic duct obstruction, with failure of adequate collateral drainage and resultant reflux of chylous lymph through lymphatics draining the heart and pericardium.24 When mechanical obstruction increases above 15 cm H2O pressure in lymphatic vessels, and when there is compression of venous collateral drainage, chylopericardium occurs.5 Although 44% of patients are asymptomatic, clinical features include dyspnea (39%), cough (12%), palpitation (3%), and chest pain (3%).2 These symptoms are similar to those observed from other pericardial effusions. Only pericardial fluid examination will give the correct diagnosis. Although the levels of fluid composition depend on the patients diet, chylous fluid is characterized by a milky appearance and cholesterol levels higher than 100 mg/dL, triglyceride levels over 1,000 mg/dL, and protein levels higher than 3 g/dL.2 The combination of lymphangiography with CT scan is an important diagnostic approach.6,7 Lymphangiography in our patient showed a connection between the thoracic duct and pericardium. In most cases, especially those associated with obstruction, a surgical approach, such as thoracic duct ligation and placement of a pleuropericardial window, may be necessary. Medical therapy should not be continued for longer than 2 weeks.6 Therapeutic goals are prevention of cardiac tamponade, constrictive pericarditis, and the loss of lymphatic fluid. Treatment usually begins with a diet rich in medium-chain triglycerides, which are directly absorbed into the portal venous system, to reduce the amount of lymph ascending into the thoracic lymphatics.4 Repeated pericardiocentesis or use of a pericardiostomy tube are necessary in less than 50% of patients.8 Our patient presented with superior vena cava syndrome caused by primary mediastinal, diffuse, large B-cell lymphoma. Isolated spontaneous chylopericardium during treatment was managed successfully only with pericardiocentesis and tube drainage. If pericardial effusion develops in non-Hodgkins lymphoma, chylopericardium should be considered as one of the differential diagnoses.
REFERENCES 1. Abraham KP, Reddy V, Gattuso P: Neoplasms metastatic to the heart: Review of 3314 consecutive autopsies. Am J Cardiovasc Pathol 3:195198, 1990[Medline] 2. Dunn RP: Primary Chylopericardium: A review of the literature and an illustrated case. Am Heart J 89:369377, 1975[CrossRef][Medline] 3. Groves LK, Effler DB: Primary chylopericardium. N Engl J Med 250:520523, 1954[Medline]
4. Andrade Santiago J, Robles L, Casimiro C: Chylopericardium of neoplastic aetiology. Ann Oncol 9:13391342, 1998 5. Csanády M, Kovásc GS: Isolated massive chylopericardium. Ann Thorac Surg 15:427435, 1973[Medline] 6. Ruska M, Spaggiari L, Carbognani D, et al: Late spontaneous chylopericardium following complex cardiac surgery. J Cardiovasc Surg 36:175176, 1995[Medline] 7. Akamatsu H, Amanu J, Sakamoto T, et al: Primary chylopericardium. Ann Thorac Surg 58:262266, 1994[Abstract] 8. Chan BB, Murphy MC, Rodgers BM: Management of chylopericardium. J Pediatr Surg 25:11851189, 1990[CrossRef][Medline]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||
|
Copyright © 2003 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|